₩21,150.00 ($15.73)

-2200.00 (-9.42%)

Weekly Expected Move ±20.3%

₩12543 ₩16846 ₩21150 ₩25454 ₩29757

KOE · Healthcare · Biotechnology · Tech Score Strong Sell · Power 25 · ₩449.1B mcap · 16M float · 1.56% daily turnover

View Full Income Statement

No data available

Line Item	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$385	$0	$24M
Cost of Revenue	$2.7B	$0	$0
Gross Profit	$385	$0	$24M
Gross Margin	100.0%	—	100.0%
R&D Expenses	$10M	$13.8B	$10.8B
SG&A Expenses	$1.5B	$1.4B	$2.0B
Operating Expenses	$12M	$18.1B	$15.4B
Operating Income	-$12M	-$18.1B	-$15.4B
Operating Margin	-3080143.3%	—	-63691.0%
Interest Expense	$478M	$469M	$482M
Income Before Tax	-$18.2B	-$15.3B	$63.4B
Tax Expense	$2.2B	$0	$0
Net Income	-$11M	-$15.3B	$63.4B
Net Margin	-2861990.4%	—	262947.9%
EPS (Diluted)	$-0.52	$-677.00	$2937.73
EBITDA	-$12M	-$14.0B	$64.7B
Shares Outstanding	21M	23M	22M

475830.KQ KOE